Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis

Prediction of Creatinine Clearance from Serum Creatinine

Donald W. Cockcroft, Henry Gault · ˜The œNephron journals/Nephron journals · 2008 · 15.4K citations

Pharmacy, Nephrology, Pharmacokinetics +15

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Dennis M. Black, Pierre D. Delmas, Richard Eastell et al. · New England Journal of Medicine · 2007 · 3K citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)

John A. Kellum, Norbert Lameire · Critical Care · 2013 · 2.8K citations · Full text

Medicine, Internal Medicine, Nephrology +16

Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

Kenneth W. Lyles, Cathleen Colón‐Emeric, Jay Magaziner et al. · New England Journal of Medicine · 2007 · 2K citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +11

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

David M. Reid, Jean‐Pierre Devogelaer, Kenneth G. Saag et al. · The Lancet · 2009 · 529 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +12